论文部分内容阅读
联合国HIV/AIDS计划署(UNAIDS)和WHO在非洲2000年4月5日正式推荐用复方磺胺甲基异恶唑预防HIV相关性感染。西方工业化国家常规应用复方磺胺甲基异恶唑预防卡氏肺囊肿性肺炎(PCP)。但是PCP在非洲的发生不是非常普遍,因而对复方磺胺甲基异恶唑的应用还存在疑问。目前
The United Nations HIV / AIDS Program (UNAIDS) and WHO officially recommended the use of sulfamethoxazole in HIV prevention-related infections in Africa on April 5, 2000. Conventional use of sulfamethoxazole in Western industrialized countries for the prevention of Kaposi’s pneumocystitis (PCP). However, the occurrence of PCP in Africa is not very common, so the use of compound sulfamethoxazole still in question. Currently